Important CIPO Update – Amendments to Canadian Patent Rules

June 10, 2022

By Claire Palmer, Ph.D. • Under 5 min read

Health Canada to Draft New Patented Medicine Prices Review Board Guidelines in the Wake of Pharmaceutical Victories

May 17, 2022

By Claire Palmer, Ph.D. • 5-10 min read

Conference Posters and Materials: Beware! They Can Constitute Prior Art

November 15, 2021

By David Fraser • 5-10 min read

Late Report of Patent Grant leads to Irretrievable Loss of Drug Patent Register Listing Rights

September 14, 2021

By Claire Palmer, Ph.D. • 5-10 min read

Effective Consent Made Easier Under the NOC Regulations

December 8, 2020

By Jamal Hakimi • Under 5 min read

The Impact of CIPO’s New Guidance on the Prosecution of Patent Applications Directed to Diagnostic Methods

November 10, 2020

By Claire Palmer, Ph.D. & Kay Palmer, Ph.D. • Under 5 min read

New Federal Court Decision Provides for Greater Protection of Combination Drugs Under CETA

August 18, 2020

By Poonam Tauh, Ph.D. • Under 5 min read

Importance of Determining Inventorship Prior to Patent Issuance

May 12, 2020

By Jamal Hakimi • Under 5 min read

Absence of a Canadian patent leaves the PMPRB powerless to control the price of Cystadrops

February 4, 2020

By Osman Ismaili • Under 5 min read

CETA agreement and the Canadian patent landscape

October 16, 2017

By Randall (Randy) Marusyk • Under 5 min read

New LCBO Subsidiary to Control Cannabis Sales in Ontario

September 13, 2017

By Randall (Randy) Marusyk • Under 5 min read

The Supreme Court of Canada Knocked Down the “Promise Doctrine” for Determining Utility

June 30, 2017

By Suzanne Hof, Ph.D. & Poonam Tauh, Ph.D. • Under 5 min read

A balance between confidentiality orders and the open court principle in patent litigation

May 23, 2017

By Randall (Randy) Marusyk • Under 5 min read

Innovative Medicines in Canada: Important Patent Questions to Ask

May 2, 2017

By Claire Palmer, Ph.D. & Kay Palmer, Ph.D. • Under 5 min read